Rockwell Medical (RMTI) Enterprise Value (2010 - 2026)

Rockwell Medical (RMTI) has reported Enterprise Value for 17 consecutive years, with -$22.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 45.93% year-over-year to -$22.6 million; the trailing twelve-month figure through Jun 2026 stood at -$22.6 million (down 45.93% YoY), and the FY2025 full-year result was -$21.7 million, down 48.26% from the prior year.
• Enterprise Value retreated to -$22.6 million in Q2 2026 per RMTI's latest filing, from -$20.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$3.7 million in Q1 2024 and bottomed at -$29.6 million in Q2 2022.
• Historically, Enterprise Value has averaged -$14.2 million across 5 years, with a median of -$14.1 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Enterprise Value soared 84.42% in 2022, then slumped 262.54% in 2025.
• Over 5 years, Enterprise Value stood at -$20.5 million in 2022, then soared by 68.15% to -$6.5 million in 2023, then tumbled by 124.52% to -$14.7 million in 2024, then tumbled by 48.26% to -$21.7 million in 2025, then decreased by 4.08% to -$22.6 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$22.6 million, -$20.4 million, and -$21.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.